Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 6.14
+0.29 (4.96%)
Apr 2, 2026, 3:29 PM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 763.2 million as of April 2, 2026. Its market cap has decreased by -52.12% in one year.
Market Cap
763.20M
Enterprise Value
908.76M
Revenue
1.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.14
Market Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 763.20M, an increase of 166.28%. That is a compound annual growth rate of 12.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 780.16M | -30.63% |
| Dec 31, 2025 | 1.12B | -46.84% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.40B |
| Sakar Healthcare | 11.09B |
| Sigachi Industries | 6.47B |
| Valiant Laboratories | 2.80B |
| Bafna Pharmaceuticals | 2.59B |
| Nectar Lifesciences | 1.81B |
| Brooks Laboratories | 1.09B |
| Alpa Laboratories | 977.55M |